Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 18/9/2020
SIETES contiene 93096 citas

 
 
 1 a 20 de 176 siguiente >>
Presentar resultados
Seleccionar todas
1.Enlace a cita original Cita con resumen
Waxmonsky JG, Pelham W 3rd, Campa A, Waschbusch DA, Li T, Marshall R, Babocsai L, Humphery H, Gnagy E, Swanson J, Hanc T, Fallahazad N, Pelham WE 4th. A randomized controlled trial of interventions for growth suppression in children with attention-deficit/hyperactivity disorder treated with central nervous system stimulants. J Am Acad Child Adolesc Psychiatry 2019:29 de agosto. [Ref.ID 103191]
2.Enlace a cita original Cita con resumen
Lean MEJ, Leslie WS, Barnes AC, Brosnahan N, Thom G, McCombie L, Peters C, Zhyzhneuskaya S, Al-Mrabeh A, Hollingsworth KG, Rodrigues A, Rehackova L, Adamson AJ, Sniehotta FF, Mathers JC, Ross HM, McIlvenna Y, Welsh P, Kean S, Ford I, McConnachie A, Messow C-M, Sattar N, Taylor R. Durability of a primary care-led weight-management intervention for remission of type 2 diabetes: 2-year results of the DiRECT open-label, cluster-randomised trial. The Lancet Diabetes & Endocrinology 2019:6 de marzo. [Ref.ID 103052]
3.Enlace a cita original Cita con resumen
Attia E, Steinglass JE, Walsh BT, Wang Y, Wu P, Schreyer C, Wildes J, Yilmaz Z, Guarda AS, Kaplan AS, Marcus MD. Olanzapine versus placebo in adult outpatients with anorexia nervosa: a randomized clinical trial. Am J Psychiatry 2019:18 de enero. [Ref.ID 103015]
4.Enlace a cita original Cita con resumen
Rothwell PPM, Cook PNR, Gaziano PJM, Price JF, Belch PJFF, Roncaglioni MC, Morimoto T, Mehta Z. Effects of aspirin on risks of vascular events and cancer according to bodyweight and dose: analysis of individual patient data from randomised trials. Lancet 2018:12 de julio. [Ref.ID 102745]
5. Cita con resumen
Nordström P, Pedersen NL, Gustafson Y, Michäelsson k, Nordström A. Risks of myocardial infarction, death, and diabetes in identical twin pairs with different body mass indexes. JAMA Intern Med 2016:1 de agosto. [Ref.ID 100560]
6. Cita con resumen
Syngelaki A, Nicolaides KH, Balani J, Hyer S, Akolekar R, Kotecha R, Pastides A, Shehata H. Metformin versus placebo in obese pregnant women withouth diabetes mellitus. N Engl J Med 2016;374:434-43. [Ref.ID 100118]
7. Cita con resumen
Lind M, Hirsch IB, Tuomilehto J, Dahlqvist S, Ahrén B, Torffvit O, Attvall S, Ekelun M, Filipsson K, Tengmark B-O, Sjöberg S, Pehrsson N-G. Liraglutide in people treated for type 2 diabetes with multiple daily insulin injections: randomised clinical trial (MDI Liraglutide trial). BMJ 2015;351:h5364. [Ref.ID 99640]
8. Cita con resumen
Anónimo. Liraglutide (Saxenda) for weight loss. Med Lett Drugs Ther 2015;57:7-8. [Ref.ID 99215]
9. Cita con resumen
Anónimo. Dilemmas in the management of osteoporosis. Drug Ther Bull 2015;53:18-21. [Ref.ID 98778]
10. Cita con resumen
Tricco AC, Ashoor HM, Antony J, Beyene J, Veroniki AA, Isaranuwatchai W, Harrington A, Wilson C, Tsouros S, Soobiah C, Yu CH, Hutton B, Hoch JS, Hemmelgarn BR, Moher D, Majumdar SR, Straus SE. Safety, effectiveness, and cost effectiveness of long acting versus intermediate acting insulin for patients with type 1 diabetes: systematic review and network meta-analysis. BMJ 2014;349:g5459. [Ref.ID 98278]
12. Cita con resumen
McCallum PK, Mathur R, Hull SA, Saja K, Green L, Morris JK, Ashman N. Patient safety and estimation of renal function in patients prescribed new oral anticoagulants for stroke prevention in atrial fibrillation: a cross-sectional study. BMJ Open 2013;3:e003343. [Ref.ID 96277]
13. Cita con resumen
Maccallum PK, Mathur R, Hull SA, Saja K, Green L, Morris JK, Ashman N. Patient safety and estimation of renal function in patients prescribed new oral anticoagulants for stroke prevention in atrial fibrillation: a cross-sectional study. BMJ Open 2013;3:27 de septiembre. [Ref.ID 96036]
14.Tiene citas relacionadas
Weber MA, Bakris GL, Weir MR, Jamerson K. Obesity, blood pressure, and cardiovascular outcomes - Authors' reply. Lancet 2013;381:1982. [Ref.ID 95608]
15.Tiene citas relacionadas
Dong S, Mao B. Obesity, blood pressure, and cardiovascular outcomes. Lancet 2013;381:1982. [Ref.ID 95607]
16.Tiene citas relacionadas
Blankfield RP. Obesity, blood pressure, and cardiovascular outcomes. Lancet 2013;381:1981. [Ref.ID 95606]
17.Tiene citas relacionadas
Barrios V, Escobar C. Obesity, blood pressure, and cardiovascular outcomes. Lancet 2013;381:1981. [Ref.ID 95605]
18.Tiene citas relacionadas
Elijovich F, Laffer C. Obesity, blood pressure, and cardiovascular outcomes. Lancet 2013;381:1981. [Ref.ID 95604]
20.Tiene citas relacionadas Cita con resumen
Weber MA, Jamerson KB, Bakris GL, Weir MR, Zappe D, Zhang Y, Dahlof B, Velázquez EJ, Pitt B. Effects of body size and hypertension treatments on cardiovascular event rates: subanalysis of the ACCOMPLISH randomised controlled trial. Lancet 2013;381:537-45. [Ref.ID 94952]
Seleccionar todas
 
 1 a 20 de 176 siguiente >>